Research Article
Pioglitazone Mediates Cardiac Progenitor Formation through Increasing ROS Levels
Figure 6
Beating area, gene expression, and percentage of embryoid body-derived precursors converted to beating heart objects in mature heart cells treated with pioglitazone in combination with two types of antioxidants. Morphological illustration (a) and beating area percentages (b) of generated mESC-derived beating EBs treated with antioxidant CoQ10 along with Pio, on the day 14. Scale bar is 200 mm. Relative expression levels of a-MHC (c), cTnT (d), and Sm22a (e) in beating EBs treated with CoQ10 along with Pio, on day 14. Represented value bars are the EM ( value < 0.05). Alphabets indicate significant difference between samples at value < 0.05. A represents significance vs. no treatment and B vs. Pio. (f) Percentages of beating EBs treated with antioxidant CoQ10 along with Pio, on the day 14.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |